190 related articles for article (PubMed ID: 32887303)
1. Phenylalanine Stereoisomers of CJ-15,208 and [d-Trp]CJ-15,208 Exhibit Distinctly Different Opioid Activity Profiles.
Brice-Tutt AC; Senadheera SN; Ganno ML; Eans SO; Khaliq T; Murray TF; McLaughlin JP; Aldrich JV
Molecules; 2020 Sep; 25(17):. PubMed ID: 32887303
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan Substitution in CJ-15,208 (
Scherrer KH; Eans SO; Medina JM; Senadheera SN; Khaliq T; Murray TF; McLaughlin JP; Aldrich JV
Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765026
[TBL] [Abstract][Full Text] [Related]
3. Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviour.
Aldrich JV; Senadheera SN; Ross NC; Reilley KA; Ganno ML; Eans SE; Murray TF; McLaughlin JP
Br J Pharmacol; 2014 Jul; 171(13):3212-22. PubMed ID: 24588614
[TBL] [Abstract][Full Text] [Related]
4. Novel opioid cyclic tetrapeptides: Trp isomers of CJ-15,208 exhibit distinct opioid receptor agonism and short-acting κ opioid receptor antagonism.
Ross NC; Reilley KJ; Murray TF; Aldrich JV; McLaughlin JP
Br J Pharmacol; 2012 Feb; 165(4b):1097-108. PubMed ID: 21671905
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional opioid receptor agonism and antagonism by a novel macrocyclic tetrapeptide prevents reinstatement of morphine-seeking behaviour.
Brice-Tutt AC; Wilson LL; Eans SO; Stacy HM; Simons CA; Simpson GG; Coleman JS; Ferracane MJ; Aldrich JV; McLaughlin JP
Br J Pharmacol; 2020 Sep; 177(18):4209-4222. PubMed ID: 32562259
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Characterization of the Macrocyclic Tetrapeptide
Ferracane MJ; Brice-Tutt AC; Coleman JS; Simpson GG; Wilson LL; Eans SO; Stacy HM; Murray TF; McLaughlin JP; Aldrich JV
ACS Chem Neurosci; 2020 May; 11(9):1324-1336. PubMed ID: 32251585
[TBL] [Abstract][Full Text] [Related]
7. The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration.
Eans SO; Ganno ML; Reilley KJ; Patkar KA; Senadheera SN; Aldrich JV; McLaughlin JP
Br J Pharmacol; 2013 May; 169(2):426-36. PubMed ID: 23425081
[TBL] [Abstract][Full Text] [Related]
8. Unexpected opioid activity profiles of analogues of the novel peptide kappa opioid receptor ligand CJ-15,208.
Aldrich JV; Kulkarni SS; Senadheera SN; Ross NC; Reilley KJ; Eans SO; Ganno ML; Murray TF; McLaughlin JP
ChemMedChem; 2011 Sep; 6(9):1739-45. PubMed ID: 21761566
[TBL] [Abstract][Full Text] [Related]
9. Versatile Picklocks To Access All Opioid Receptors: Tuning the Selectivity and Functional Profile of the Cyclotetrapeptide c[Phe-d-Pro-Phe-Trp] (CJ-15,208).
De Marco R; Bedini A; Spampinato S; Cavina L; Pirazzoli E; Gentilucci L
J Med Chem; 2016 Oct; 59(19):9255-9261. PubMed ID: 27607020
[TBL] [Abstract][Full Text] [Related]
10. An analog of [d-Trp]CJ-15,208 exhibits kappa opioid receptor antagonism following oral administration and prevents stress-induced reinstatement of extinguished morphine conditioned place preference.
Brice-Tutt AC; Eans SO; Yakovlev D; Aldrich JV; McLaughlin JP
Pharmacol Biochem Behav; 2022 Jun; 217():173405. PubMed ID: 35584724
[TBL] [Abstract][Full Text] [Related]
11. Development of a robust, sensitive and selective liquid chromatography-tandem mass spectrometry assay for the quantification of the novel macrocyclic peptide kappa opioid receptor antagonist [D-Trp]CJ-15,208 in plasma and application to an initial pharmacokinetic study.
Khaliq T; Williams TD; Senadheera SN; Aldrich JV
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():11-15. PubMed ID: 27318293
[TBL] [Abstract][Full Text] [Related]
12. The macrocyclic peptide natural product CJ-15,208 is orally active and prevents reinstatement of extinguished cocaine-seeking behavior.
Aldrich JV; Senadheera SN; Ross NC; Ganno ML; Eans SO; McLaughlin JP
J Nat Prod; 2013 Mar; 76(3):433-8. PubMed ID: 23327691
[TBL] [Abstract][Full Text] [Related]
13. Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid Receptors.
Eans SO; Ganno ML; Mizrachi E; Houghten RA; Dooley CT; McLaughlin JP; Nefzi A
J Med Chem; 2015 Jun; 58(12):4905-17. PubMed ID: 25996309
[TBL] [Abstract][Full Text] [Related]
14. Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays.
Bonner GG; Davis P; Stropova D; Edsall S; Yamamura HI; Porreca F; Hruby VJ
J Med Chem; 2000 Feb; 43(4):569-80. PubMed ID: 10691683
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
Vig BS; Murray TF; Aldrich JV
J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
[TBL] [Abstract][Full Text] [Related]
16. Nascent structure-activity relationship study of a diastereomeric series of kappa opioid receptor antagonists derived from CJ-15,208.
Dolle RE; Michaut M; Martinez-Teipel B; Seida PR; Ajello CW; Muller AL; DeHaven RN; Carroll PJ
Bioorg Med Chem Lett; 2009 Jul; 19(13):3647-50. PubMed ID: 19464172
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive activity of thiazole-containing cyclized DAMGO and Leu-(Met) enkephalin analogs.
Harris HM; Eans SO; Ganno ML; Davis JC; Dooley CT; McLaughlin JP; Nefzi A
Org Biomol Chem; 2019 Jun; 17(21):5305-5315. PubMed ID: 31094391
[TBL] [Abstract][Full Text] [Related]
18. Bis-Cyclic Guanidine Heterocyclic Peptidomimetics as Opioid Ligands with Mixed μ-, κ- and δ-Opioid Receptor Interactions: A Potential Approach to Novel Analgesics.
McLaughlin JP; Rayala R; Bunnell AJ; Tantak MP; Eans SO; Nefzi K; Ganno ML; Dooley CT; Nefzi A
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077029
[TBL] [Abstract][Full Text] [Related]
19. The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice.
Anand JP; Boyer BT; Mosberg HI; Jutkiewicz EM
Psychopharmacology (Berl); 2016 Jul; 233(13):2479-87. PubMed ID: 27117141
[TBL] [Abstract][Full Text] [Related]
20. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
